Tuberculosis
Tuberculosis ( 23 Questions)
The most appropriate intervention for a client diagnosed with latent TB infection (LTBI) is observation for disease progression. Latent TB infection means that the individual has been infected with the tuberculosis bacteria but does not currently have active TB disease. In cases of LTBI, the bacteria are in a dormant state, and the person does not show any symptoms. The standard approach for LTBI management is to monitor the individual closely for any signs of disease progression. This may involve regular clinical assessments and follow-ups to detect the development of active TB. Initiating treatment (such as INH administration) is not recommended for all individuals with LTBI, as not everyone with latent infection will progress to active disease. The decision to treat depends on the individual's risk factors, clinical presentation, and other considerations. Selecting choice B (Sputum smear microscopy) is not appropriate for LTBI since this test is used to diagnose active TB disease, not latent infection.
No explanation
C (Tuberculin skin test, TST) is used to identify individuals with LTBI, not as an intervention for those already diagnosed with LTBI.
D (INH administration) may be a treatment option for certain individuals with LTBI, but it is not the most appropriate intervention for all LTBI cases.
E (Contact tracing) is a strategy to identify and screen individuals who may have been exposed to active TB cases, not a direct intervention for LTBI management.
Choice A rationale:
The most appropriate intervention for a client diagnosed with latent TB infection (LTBI) is observation for disease progression. Latent TB infection means that the individual has been infected with the tuberculosis bacteria but does not currently have active TB disease. In cases of LTBI, the bacteria are in a dormant state, and the person does not show any symptoms. The standard approach for LTBI management is to monitor the individual closely for any signs of disease progression. This may involve regular clinical assessments and follow-ups to detect the development of active TB. Initiating treatment (such as INH administration) is not recommended for all individuals with LTBI, as not everyone with latent infection will progress to active disease. The decision to treat depends on the individual's risk factors, clinical presentation, and other considerations. Selecting choice B (Sputum smear microscopy) is not appropriate for LTBI since this test is used to diagnose active TB disease, not latent infection. Choice C (Tuberculin skin test, TST) is used to identify individuals with LTBI, not as an intervention for those already diagnosed with LTBI. Choice D (INH administration) may be a treatment option for certain individuals with LTBI, but it is not the most appropriate intervention for all LTBI cases. Choice E (Contact tracing) is a strategy to identify and screen individuals who may have been exposed to active TB cases, not a direct intervention for LTBI management.